CACI insider plans sale of 4,962 common shares

CACI International Inc. reported a planned sale of 4,962 shares of common stock through UBS Financial Services Inc. on August 10, 2026, to be executed on the NYSE.

Rhea-AI Filing Summary

CACI International Inc. reported a planned sale of 4,962 shares of common stock through UBS Financial Services Inc. on August 10, 2026, to be executed on the NYSE. These shares trace to RSU vestings dated June 5, 2019 (2,201 shares) and June 5, 2020 (2,761 shares), with an indicated aggregate market value of $3,195,578.11.

Key Figures

Shares planned for sale: 4,962 shares Aggregate market value: $3,195,578.11 RSU vesting 2019: 2,201 shares +2 more

5 metrics

Shares planned for sale 4,962 shares Common stock to be sold on August 10, 2026 on NYSE

Aggregate market value $3,195,578.11 Reported value of 4,962 common shares in Form 144

RSU vesting 2019 2,201 shares Shares from June 5, 2019 RSU vesting listed to be sold

RSU vesting 2020 2,761 shares Shares from June 5, 2020 RSU vesting listed to be sold

Planned sale date 08/10/2026 Date for sale of listed common stock on NYSE

Key Terms

Form 144, RSU Vesting, aggregate market value, Common Stock

4 terms

Form 144 regulatory

"Form 144: Securities Information and planned stock sale"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

RSU Vesting financial

"Common Stock | 06/05/2019 | RSU Vesting | CACI International Inc."

RSU vesting is the process by which restricted stock units — a promise by a company to give shares to an employee — become actual, owned shares over time or when certain goals are met. Investors care because vested shares can dilute existing ownership when issued, and the timing of vesting affects when employees can sell shares, which can influence share supply, insider selling patterns, and company incentives.

aggregate market value financial

"Common Stock | UBS Financial Services Inc ... 3195578.11"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Common Stock financial

"Common Stock | UBS Financial Services Inc 1000 Harbor Blvd"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing by CACI (CACI) disclose?

The filing discloses a planned sale of 4,962 shares of CACI International Inc. common stock, to be sold through UBS Financial Services Inc. on August 10, 2026 on the NYSE.

How many CACI (CACI) shares are planned to be sold and at what value?

The notice covers 4,962 shares of CACI common stock with an indicated aggregate market value of $3,195,578.11, as reported in the Form 144 securities information section.

What is the origin of the CACI (CACI) shares in this Form 144?

The shares originate from RSU vestings on June 5, 2019 (2,201 shares) and June 5, 2020 (2,761 shares), both in CACI International Inc. common stock, now listed as securities to be sold.

When are the CACI (CACI) shares expected to be sold under this Form 144?

The planned sale date reported is August 10, 2026, with the common stock to be sold on the NYSE through UBS Financial Services Inc., according to the securities information table.

Which broker is handling the planned CACI (CACI) Form 144 stock sale?

The planned sale of 4,962 CACI shares will be handled by UBS Financial Services Inc., listed with its Weehawken, NJ address in the securities information section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/10/2026 - 04:48 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001708409
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CACI International Inc.
SEC File Number	001-31400
Address of Issuer	12021 Sunset Hills Road Reston VIRGINIA 20190
Phone	703-841-7800
Name of Person for Whose Account the Securities are To Be Sold	DeEtte Gray
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	4962	3195578.11	22091305	08/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/05/2019	RSU Vesting	CACI International Inc.			2201	08/10/2026	N/A
Common Stock	06/05/2020	RSU Vesting	CACI International Inc.			2761	08/10/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for DeEtte Gray
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)